Company Filing History:

9 out of 4,442

Eli Lilly and Company

Elan Pharmaceuticals, Inc.

patents

4. 1 out of 35

Athena Neurosciences, Inc.

patents

5. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2008

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7365053 - Selective N-acylation of A82846 glygopeptides analogs (2008-04-29),

2. 6939947 - N1-modified glycopeptides (2005-09-06),

3. 6906056 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-06-14),

4. 6838455 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds (2005-01-04),

5. 6774125 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2004-08-10),

6. 6670446 - N1 modified glycopeptides (2003-12-30),

7. 6569851 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-05-27),

8. 6552013 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-04-22),

9. 6509331 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-01-21),

10. 5977063 - Alkylated hexapeptides (1999-11-02),

11. 5977062 - Glycopeptide antibiotic derivatives (1999-11-02),

12. 5952310 - Glycopeptide hexapeptides (1999-09-14),

13. 5843889 - Glycopeptide antibiotic derivatives (1998-12-01),

14. 5840684 - Glycopeptide antibiotic derivatives (1998-11-24),

Title: The Innovative Contributions of Stephen Charles Wilkie

Introduction

Stephen Charles Wilkie, an accomplished inventor based in Indianapolis, IN, has made significant strides in the field of glycopeptides, holding a total of 14 patents throughout his career. His work has largely focused on developing innovative methods and compounds that have important applications, particularly in antibacterial treatments.

Latest Patents

Among his most recent contributions is the patent titled "Selective N-acylation of A82846 glycopeptides analogs." This invention provides a novel process for selectively acylating various analogs of the A82846 glycopeptide at specific N1, N2, or N3 positions, generating monoacylated compounds that are of considerable interest in medicinal chemistry. Additionally, Wilkie has contributed to the field with his patent on "N1-modified glycopeptides," which introduces N-acylated derivatives of desleucylA82846B, known for their utility as antibacterial agents.

Career Highlights

Throughout his professional journey, Stephen Wilkie has worked for notable companies, including Eli Lilly and Company, where he played a crucial role in advancing pharmaceutical innovations. His expertise and dedication to the field of biochemistry have driven him to develop several groundbreaking inventions, improving the landscape of antibacterial research and treatment.

Collaborations

Wilkie’s career has also been marked by fruitful collaborations with esteemed colleagues such as Richard Craig Thompson and James E Audia. These partnerships have fostered a creative environment that has led to significant advancements in their joint research endeavors.

Conclusion

Stephen Charles Wilkie is a notable inventor whose contributions, particularly in the development of glycopeptide compounds, have made a meaningful impact in the realm of medical science. With a portfolio of 14 patents, his innovations continue to pave the way for new antibacterial therapies, highlighting his role as a leading figure in this specialized field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.